ExecutiveOrdersEO
EO 14433Executive OrderTrump 47 · R

Executive Order 14433

Eliminating Disease-Carrying Pests and Restoring Enjoyment of the Great Outdoors

HealthcareHealthcareEnergy & EnvironmentEnergy & EnvironmentFederal WorkforceFederal WorkforceOtherOther

In simple terms

This executive order directs federal agencies to develop a multi-pronged campaign to suppress tick and mosquito populations, particularly in Washington, D.C., using non-chemical and technology-enabled methods including sterile insect techniques and biotechnology. It sets specific population reduction targets (90% for invasive mosquitoes, 50% for ticks by 2028), mandates regulatory frameworks for novel pest control technologies, and launches prize competitions for diagnostics, therapeutics, and non-chemical control methods for vector-borne diseases.

Federal Register Open PDF 91 FR 63125

Record & deadlines

  1. Signed

    Signed by the President

  2. FR published

    Published in the Federal Register · 91 FR 63125

    Federal Register PDF
  3. In 53d

    EPA regulatory framework for advanced pest control technologies due; campaign development begins; alpha-gal labeling exploration due

  4. HHS prize competitions for diagnostics/therapeutics; alpha-gal immunotherapy review; Agriculture prize competitions for non-chemical methods

  5. 90% invasive mosquito reduction and 50% tick reduction target in DC

Market exposure

Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

Sectors

PharmaAgricultureTechnology & softwareChemicalsOther industrial

Mechanisms

Subsidy / incentiveProcurementLicensing

Role pressure

  • ProtectiveDomestic producer — Prize competitions and expedited EPA registration create preferential pathways for US-based biotech firms developing novel pest control solutions
  • MixedEquipment supplier — Natural control methods (landscaping, drainage) may benefit some suppliers while reduced chemical use could disadvantage conventional pesticide suppliers
  • UncertainDownstream manufacturer — Food and drug manufacturers face potential new alpha-gal labeling requirements that could increase compliance costs but improve market transparency

Geographies

US

Exposure dates

  • — EPA regulatory framework for advanced pest control technologies due; campaign development begins; alpha-gal labeling exploration due
  • — HHS prize competitions for diagnostics/therapeutics; alpha-gal immunotherapy review; Agriculture prize competitions for non-chemical methods

Illustrative public companies

Curated watchlist matches by sector/role — incomplete; not a recommendation.

MMM3MALBAlbemarleGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillarCTVACortevaDEDeereDOWDowDDDuPontLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywellQQQInvesco QQQ TrustJNJJohnson & JohnsonLYBLyondellBasellMRKMerckMETAMeta PlatformsMSFTMicrosoftNVSNovartisNVDANVIDIA

Confidence: medium · Policy alerts

Key directives

  • Develop and implement DC-wide campaign to reduce Asian tiger and Egyptian mosquito populations by 90% and tick populations by 50% by 2028
  • EPA to submit regulatory framework for advanced tick/mosquito control technologies within 60 days
  • EPA to prioritize and expedite registration of novel safe and effective control methods
  • HHS to issue prize competitions for rapid diagnostics, prophylactics, and therapeutics within 90 days
  • HHS to review alpha-gal immunotherapies and develop accelerated clinical review agenda within 90 days
  • Agriculture to issue prize competitions for non-chemical pest reduction methods within 90 days
  • Agriculture and HHS to explore alpha-gal food/drug labeling options within 60 days
  • Agency heads to review available resources with OMB Director

Who is ordered

Related orders

What to expect

Immediate

  • Campaign planning begins across Interior, Agriculture, EPA, GSA, and HHS
  • EPA begins developing regulatory framework for biotechnology pest controls

Near term (90d)

  • EPA submits regulatory framework for tick/mosquito control technologies
  • HHS issues prize competitions for diagnostics, prophylactics, therapeutics
  • HHS reviews alpha-gal immunotherapy candidates and develops research agenda
  • Agriculture issues prize competitions for non-chemical pest reduction methods
  • Agriculture and HHS explore alpha-gal food/drug labeling options
  • Agencies review available budget resources for implementation

Long term

  • By 2028: 90% reduction in invasive mosquito populations in DC
  • By 2028: 50% reduction in tick populations in DC with further reductions as practicable
  • Potential nationwide expansion of DC control techniques
  • Development and potential deployment of novel biotechnologies for pest control

Risks & tensions

  • Biotechnology release into environment faces potential ecological and public acceptance risks; alignment with EO 14292 on biological research safety suggests awareness of biosafety concerns
  • Ambitious 2028 population reduction targets may conflict with 'without negative effects on beneficial insects' mandate and resource constraints
  • 'Subject to availability of appropriations' clause may limit implementation if Congress does not fund
  • Expedited EPA registration could tension with standard safety review timelines
  • Federal jurisdiction limitations in DC may complicate implementation on non-federal lands
Executive Order 14433: Eliminating Disease-Carrying Pests and Restoring Enjoyment of the Great Outdoors · Executive Orders